Clinical Trials Directory

Trials / Completed

CompletedNCT02043223

Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit

Stopping Postpartum Vitamin A Supplementation: Are we Missing Concealed Benefit?

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
160 (actual)
Sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh · Academic / Other
Sex
Female
Age
18 Years – 32 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the effect of post-partum maternal vitamin A supplementation on breast milk bioactive compounds and immune status, growth and morbidity of children in the first four months of life.

Detailed description

The effect will be assessed by the milk and blood.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin A (<3-day postpartum)Single dose 200,000 IU vitamin A supplementation at \<3-day and placebo supplementation at 6-wk postpartum.
DIETARY_SUPPLEMENTVitamin A (6 wk postpartum)Placebo supplementation at \<3-day and single dose 200,000 IU vitamin A supplementation at 6-wk postpartum.
DIETARY_SUPPLEMENTVitamin A (<3-day and 6 wk postpartum)200,000 IU vitamin A supplementation, both at \<3-day and 6-wk postpartum
DIETARY_SUPPLEMENTPlaceboPlacebo supplementation, both at \<3-day and 6-wk postpartum.

Timeline

Start date
2013-10-01
Primary completion
2016-07-01
First posted
2014-01-23
Last updated
2016-09-21

Locations

1 site across 1 country: Bangladesh

Source: ClinicalTrials.gov record NCT02043223. Inclusion in this directory is not an endorsement.

Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit (NCT02043223) · Clinical Trials Directory